Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling

Yongping Zhou1, Ting Shan2, Wenzhou Ding1

  • 1Department of Hepatobiliary, Wuxi Second Hospital, Nanjing Medical University, Wuxi, Jiangsu, China.

Insights

High expression of long non-coding RNA MALAT1 in pancreatic cancer (PC) promotes tumor growth and metastasis by inhibiting the Hippo-YAP signaling pathway. Silencing MALAT1 reduces proliferation and invasion, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Pancreatic cancer (PC) is a highly aggressive malignancy with poor prognosis.
  • Long non-coding RNAs (lncRNAs) play critical roles in cancer development and progression.
  • The Hippo-YAP signaling pathway is frequently dysregulated in various cancers, including PC.

Purpose of the Study:

  • To investigate the molecular mechanism of lncRNA MALAT1 in pancreatic cancer.
  • To explore the role of lncRNA MALAT1 in regulating the Hippo-YAP signaling pathway.
  • To assess the impact of lncRNA MALAT1 on cancer cell proliferation, apoptosis, migration, and invasion.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) and Western blot to detect MALAT1, LATS1, and YAP1 expression.
  • Cell Counting Kit-8 (CCK-8) assay for proliferation.
  • Flow cytometry for apoptosis.
  • Wound healing and Transwell assays for migration and invasion.
  • Immunohistochemistry and in vivo tumor xenograft models.

Main Results:

  • lncRNA MALAT1 was highly expressed in PC tissues and cells.
  • Silencing MALAT1 (si-MALAT1) decreased proliferation, induced apoptosis, and reduced migration and invasion of PC cells (AsPC-1).
  • MALAT1 dysregulated LATS1 (down-regulated) and YAP1 (up-regulated) expression within the Hippo-YAP pathway, leading to increased tumor growth and Ki-67 expression in vivo.

Conclusions:

  • High expression of lncRNA MALAT1 in pancreatic cancer promotes tumor progression.
  • lncRNA MALAT1 influences proliferation, apoptosis, migration, and invasion by modulating the Hippo-YAP signaling pathway.
  • lncRNA MALAT1 represents a potential therapeutic target for pancreatic cancer treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.8K